Dr. Alfred Maelicke
Managing Director
management
Neurodyn
Canada
Biography
Dr. Alfred Maelicke is Neurodyn’s Managing Director | Europe. A graduate of Goettingen and Saarbrucken Universities, he is both Founder and CEO of Galantos Pharma GmbH and has decades of experience in neuropharmacology, drug development, preclinical pharmacology and safety. He is the inventor of Memogain® – Neurodyn’s patent-protected synthetic derivative of the natural cognitive enhancer galantamine. In his role, he is managing clinical development of Memogain® in Alzheimer’s disease and other CNS indications, manufacturing and regulatory processes for market introduction, mode of action studies of nicotinic modulators, and formulation development for enhanced brain penetration.
Research Interest
Alzheimer’s disease
